Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit.

@article{Swoboda2008TigecyclineFT,
  title={Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit.},
  author={Stefanie Swoboda and Michael H. Ober and Christian Hainer and C Lichtenstern and Christoph Seiler and Constanze Wendt and Torsten Hoppe-Tichy and Markus H Buechler and Markus Alexander Weigand},
  journal={The Journal of antimicrobial chemotherapy},
  year={2008},
  volume={61 3},
  pages={729-33}
}
OBJECTIVES Adequate antimicrobial therapy is crucial for the survival of critically ill patients with severe nosocomial infections. Tigecycline, the first available agent in the new class of glycylcyclines, is active against multiresistant gram-positive and gram-negative bacteria. The aim of this observational, retrospective evaluation was to assess tigecycline use patterns in a surgical intensive care unit (SICU) of a tertiary care centre. METHODS Data from 70 patients receiving tigecycline… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Similar Papers

Loading similar papers…